Anne L. Peters

Endocrinology

9033 Wilshire Blvd Ste 406
Beverly Hills, CA 90211

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 194 publications

Insulin Costs and Use by Medicare Beneficiaries After the Inflation Reduction Act Out-of-Pocket Cap.

Insulin Costs and Use by Medicare Beneficiaries After the Inflation Reduction Act Out-of-Pocket Cap.

Journal: JAMA

Published: June 06, 2026

SGLT Inhibitors for Heart and Kidney Disease in Type 1 Diabetes.

SGLT Inhibitors for Heart and Kidney Disease in Type 1 Diabetes.

Journal: Diabetes care

Published: May 04, 2026

Impact of Prior Authorization Suspension on Access to Diabetes Technology in an Underserved Population: A Retrospective Analysis.

Impact of Prior Authorization Suspension on Access to Diabetes Technology in an Underserved Population: A Retrospective Analysis.

Journal: Diabetes care

Published: February 05, 2026

Stem Cell-Derived, Fully Differentiated Islets for Type 1 Diabetes.

Stem Cell-Derived, Fully Differentiated Islets for Type 1 Diabetes.

Journal: The New England journal of medicine

Published: June 22, 2025

Prediabetes.

Prediabetes.

Journal: Nature reviews. Disease primers

Published: June 19, 2025

Challenges in and opportunities for individualising diabetes technology: a position statement by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group.

Challenges in and opportunities for individualising diabetes technology: a position statement by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group.

Journal: Diabetologia

Published: February 28, 2025

Challenges in and Opportunities for Individualizing Diabetes Technology: A Position Statement by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group.

Challenges in and Opportunities for Individualizing Diabetes Technology: A Position Statement by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group.

Journal: Diabetes care

Published: February 28, 2025

Automated Insulin Delivery in Adults With Type 2 Diabetes: A Nonrandomized Clinical Trial.

Automated Insulin Delivery in Adults With Type 2 Diabetes: A Nonrandomized Clinical Trial.

Journal: JAMA network open

Published: February 14, 2025

Expert Clinical Interpretation of Continuous Glucose Monitor Reports From Individuals Without Diabetes.

Expert Clinical Interpretation of Continuous Glucose Monitor Reports From Individuals Without Diabetes.

Journal: Journal of diabetes science and technology

Published: February 12, 2025

Semaglutide for Weight Reduction in Type 1 Diabetes: Promising Results With Uncertain Glycemic Impact.

Semaglutide for Weight Reduction in Type 1 Diabetes: Promising Results With Uncertain Glycemic Impact.

Journal: Journal of diabetes science and technology

Published: December 10, 2024

Practical considerations for using the Omnipod® 5 Automated Insulin Delivery System: Clinical experience from the United States and Europe.

Practical considerations for using the Omnipod® 5 Automated Insulin Delivery System: Clinical experience from the United States and Europe.

Journal: Diabetes, obesity & metabolism

Published: November 26, 2024

Quantifying Environmental Waste From Diabetes Devices in the U.S.

Quantifying Environmental Waste From Diabetes Devices in the U.S.

Journal: Diabetes care

Published: November 15, 2024

Showing 1-12 of 194

Last Updated: 09/26/2026